# Lonza Guangzhou Pharmaceutical Ltd., Guangzhou, China – FDA Inspections

Source: https://www.keypedia.com/companies/lonza-guangzhou-pharmaceutical-ltd/eeb8d307-3663-4559-88cd-4e0696c0b556

> Inspection records and compliance data for Lonza Guangzhou Pharmaceutical Ltd. in Guangzhou. 5 FDA inspections on record, 1 Form 483, last inspected October 31, 2025.

---

## Details

- Name: Lonza Guangzhou Pharmaceutical Ltd.
- FEI Number: 3006532186
- Address Line 1: 68 Huangge Dadaobei Aozhou Jie Si Xiang, Huanggezhen Nansha Fanyu
- City: Guangzhou
- Country Name: China
- Address: 68 Huangge Dadaobei Aozhou Jie Si Xiang, Huanggezhen Nansha Fanyu, Guangzhou, China
- Country: China

## Related Documents

- [483 - Lonza Guangzhou Pharmaceutical Ltd. - 2025-10-31](https://www.keypedia.com/records/483/lonza-guangzhou-pharmaceutical-ltd/b9411a55-c9a2-446b-b943-96edfbf389b1) — source: FDA, date: October 31, 2025
- [FDA Inspection 1292806 - Lonza Guangzhou Pharmaceutical Ltd. - 2025-10-31](https://www.keypedia.com/records/fda_inspections/lonza-guangzhou-pharmaceutical-ltd/6df8e4c7-99a4-4669-85d6-191812ef13ce) — source: FDA, date: October 31, 2025
- FDA Inspection 1292806 - Lonza Guangzhou Pharmaceutical Ltd. - 2025-10-31 — source: FDA, date: October 31, 2025
- FDA Inspection 1077023 - Lonza Guangzhou Pharmaceutical Ltd. - 2018-12-14 — classification: No Action Indicated (NAI), source: FDA, date: December 14, 2018
- FDA Inspection 981011 - Lonza Guangzhou Pharmaceutical Ltd. - 2016-08-19 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 19, 2016
- [FDA Inspection 846043 - Lonza Guangzhou Pharmaceutical Ltd. - 2013-08-23](https://www.keypedia.com/records/fda_inspections/lonza-guangzhou-pharmaceutical-ltd/6173e794-a20c-4232-b5fe-2d603c6d7df3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 23, 2013
- FDA Inspection 709669 - Lonza Guangzhou Pharmaceutical Ltd. - 2010-12-04 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 4, 2010

## Related Companies

- [Shandong Xinhua Pharmaceutical Company Limited](https://www.keypedia.com/companies/shandong-xinhua-pharmaceutical-company-limited/7350901d-493e-45cb-a67f-c73093cf762e)
- [Veranova LP](https://www.keypedia.com/companies/veranova-lp/50498286-71e6-4129-9abb-5c2c51ef0a41)
- [Cambrex Profarmaco Milano Srl](https://www.keypedia.com/companies/cambrex-profarmaco-milano-srl/5855fd12-020f-4975-9bc0-f5358c581aef)
- [Delta Synthetic Co. Ltd.](https://www.keypedia.com/companies/delta-synthetic-co-ltd/9b545bf3-4b7b-4b93-aa26-b3c6b41d9a52)
- [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/4c885aaa-7cca-44f3-a475-13a83042c513)
- [Curia Global, Inc.](https://www.keypedia.com/companies/curia-global-inc/70463a22-7e8e-48fc-9c8d-f781da625c4c)
- [PCAS Finland Oy](https://www.keypedia.com/companies/pcas-finland-oy/19918537-642f-4d1a-a55b-d8c267e069df)
- [Ajinomoto Co., Inc.](https://www.keypedia.com/companies/ajinomoto-co-inc/0cddfef7-b7e4-499f-81aa-0d5e77d331d4)
- [MSD International GmbH](https://www.keypedia.com/companies/msd-international-gmbh/a9448cbd-d3cc-4427-a1d5-22dc511c3c07)
- [Hangzhou Huadong Medicine Group Zhejiang Huayi Pharmaceutical Co., LTD.](https://www.keypedia.com/companies/hangzhou-huadong-medicine-group-zhejiang-huayi-pharmaceutical-co-ltd/4fcabfd2-d6e5-41ab-a543-fd9b939f8430)

## Related Officers

- [Jose M. Cayuela](https://www.keypedia.com/people/jose-m-cayuela/3ee89bb5-4bba-493b-816f-31b8a9768025)
- [David V. Ward](https://www.keypedia.com/people/david-v-ward/14bb7fc5-296b-4d14-bd3e-4c6ce5ac5cc2)